Literature DB >> 16049372

Hydrolysis of myelin basic protein by IgM and IgA antibodies from the sera of patients with multiple sclerosis.

Dar'ya I Polosukhina1, Valentina N Buneva, Boris M Doronin, Olga B Tyshkevich, Alexey N Boiko, Evgenii I Gusev, Olga O Favorova, Gregory A Nevinsky.   

Abstract

BACKGROUND: The presence of abzymes (Abzs) in human sera is a specific feature of different autoimmune pathologies. We have shown that IgGs of patients with multiple sclerosis (MS) specifically hydrolyze human myelin basic protein (hMBP). However, the presence of hMBP-hydrolyzing MS IgMs and IgAs in patients with MS has not been studied. MATERIAL/
METHODS: Homogeneous IgM and IgA fractions were isolated from human sera by affinity chromatography on different adsorbents. The Ab-dependent hydrolysis of hMBP was analyzed using SDS-PAGE.
RESULTS: We present evidence showing that MS IgMs and IgAs (but not Abs from the sera of healthy individuals) catalyze the hydrolysis of hMBP. Specific enzymatic activities of IgMs and sIgAs from sera of any single patient were usually significantly higher than those of IgGs. Specific inhibitors of acidic and thiol proteases demonstrated a weak effect on proteolytic activity of IgGs and IgMs. However, specific inhibitors of serine proteases (AEBSF, PMSF, and benzamidine) significantly inhibited proteolytic activity. IgMs and IgAs hydrolyze specifically both human and pig MBP but not many other tested proteins. Although the biological function of this proteolytic activity is not known, it is clear that MBP-hydrolyzing Abs may play an important role in MS pathogenesis.
CONCLUSIONS: The findings display the generation by the immune systems of individual MS patients of a variety of polyclonal IgGs, IgMs, and IgAs with different proteolytic properties, which hydrolyze MBP, the major protein component of the myelin-proteolipid shell of axons and a well-known MS autoantigen.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16049372

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  19 in total

1.  Naturally occurring catalytic antibodies: evidence for preferred development of the catalytic function in IgA class antibodies.

Authors:  Yukie Mitsuda; Stephanie Planque; Mariko Hara; Robert Kyle; Hiroaki Taguchi; Yasuhiro Nishiyama; Sudhir Paul
Journal:  Mol Biotechnol       Date:  2007-06       Impact factor: 2.695

2.  Comparison of antibodies hydrolyzing myelin basic protein from the cerebrospinal fluid and serum of patients with multiple sclerosis.

Authors:  Visilii B Doronin; Taisiya A Parkhomenko; Massimiliano Castellazzi; Marina Padroni; Michela Pastore; Valentina N Buneva; Enrico Granieri; Georgy A Nevinsky
Journal:  PLoS One       Date:  2014-09-29       Impact factor: 3.240

3.  Catalase activity of IgG antibodies from the sera of healthy donors and patients with schizophrenia.

Authors:  Evgeny A Ermakov; Ludmila P Smirnova; Nikolay A Bokhan; Arkadiy V Semke; Svetlana A Ivanova; Valentina N Buneva; Georgy A Nevinsky
Journal:  PLoS One       Date:  2017-09-25       Impact factor: 3.240

4.  Multiple sites of the cleavage of 21- and 25-mer encephalytogenic oligopeptides corresponding to human myelin basic protein (MBP) by specific anti-MBP antibodies from patients with systemic lupus erythematosus.

Authors:  Anna M Timofeeva; Pavel S Dmitrenok; Ludmila P Konenkova; Valentina N Buneva; Georgy A Nevinsky
Journal:  PLoS One       Date:  2013-03-08       Impact factor: 3.240

5.  Affinity and catalytic heterogeneity of polyclonal myelin basic protein-hydrolyzing IgGs from sera of patients with multiple sclerosis.

Authors:  Galina A Legostaeva; Dar'ya I Polosukhina; Anna M Bezuglova; Boris M Doronin; Valentina N Buneva; Georgy A Nevinsky
Journal:  J Cell Mol Med       Date:  2009-03-06       Impact factor: 5.310

6.  Comparison of DNA-hydrolyzing antibodies from the cerebrospinal fluid and serum of patients with multiple sclerosis.

Authors:  Taisiya A Parkhomenko; Vasilii B Doronin; Massimiliano Castellazzi; Marina Padroni; Michela Pastore; Valentina N Buneva; Enrico Granieri; Georgy A Nevinsky
Journal:  PLoS One       Date:  2014-04-15       Impact factor: 3.240

7.  Comparison of Antibodies with Amylase Activity from Cerebrospinal Fluid and Serum of Patients with Multiple Sclerosis.

Authors:  Vasilii B Doronin; Taisiya A Parkhomenko; Massimiliano Castellazzi; Edward Cesnik; Valentina N Buneva; Enrico Granieri; Georgy A Nevinsky
Journal:  PLoS One       Date:  2016-05-19       Impact factor: 3.240

8.  Changes in different parameters, lymphocyte proliferation and hematopoietic progenitor colony formation in EAE mice treated with myelin oligodendrocyte glycoprotein.

Authors:  Vasilii B Doronin; Taisiya A Parkhomenko; Alexey Korablev; Ludmila B Toporkova; Julia A Lopatnikova; Alina A Alshevskaja; Sergei V Sennikov; Valentina N Buneva; Thomas Budde; Sven G Meuth; Irina A Orlovskaya; Nelly A Popova; Georgy A Nevinsky
Journal:  J Cell Mol Med       Date:  2015-10-23       Impact factor: 5.310

9.  Substrate specificity of healthy human sera IgG antibodies with peroxidase and oxydoreductase activities.

Authors:  Anna S Tolmacheva; Evgeny A Ermakov; Valentina N Buneva; Georgy A Nevinsky
Journal:  R Soc Open Sci       Date:  2018-01-31       Impact factor: 2.963

Review 10.  Interrelation of Diet, Gut Microbiome, and Autoantibody Production.

Authors:  Ioanna Petta; Judith Fraussen; Veerle Somers; Markus Kleinewietfeld
Journal:  Front Immunol       Date:  2018-03-06       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.